Trial intelligence / Profile preview

Effects of different vasopressors on innate immune response during human endotoxemia

2015-002706-36Phase 4Completed

Sponsor
Radboudumc
Start
Oct 2015
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of norepinephrine, phenylephrine and vasopressin in endotoxemia (4 arms), sponsored by Radboudumc. Started Oct 2015; status: completed.

02

Drugs

norepinephrinephenylephrinevasopressin
03

Conditions

endotoxemia

Beyond the preview

Go deeper on 2015-002706-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-002706-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call